<DOC>
	<DOCNO>NCT01413581</DOCNO>
	<brief_summary>The purpose study demonstrate rhBSSL improve growth preterm infant compare placebo .</brief_summary>
	<brief_title>Comparison rhBSSL With Placebo When Added Infant Formula Pasteurized Breast Milk During 4 Weeks Treatment Preterm Infants</brief_title>
	<detailed_description>The purpose study demonstrate rhBSSL improve growth preterm infant compare placebo . The infant bear week 32 gestational age . The study drug , rhBSSL placebo , administer 4 week treatment period add either infant formula pasteurize breast milk . The study also evaluate safety tolerability rhBSSL . Eligible patient randomize ratio 1:1 ( rhBSSL : placebo ) . The study consist maximum 1 week screening period , 4-week treatment period 2 year follow-up period .</detailed_description>
	<mesh_term>Bile Acids Salts</mesh_term>
	<criteria>Preterm infant bear week 32 gestation . Preterm infant le 33 week postmenstrual age time randomization . Preterm infant appropriate gestational age ( AGA ) small gestational age ( SGA ) birth . Preterm infant receive food enterally ( bottle gavage tube ) level least 100 ml/kg/day randomization . Preterm infant whose enteral feeding consist infant formula pasteurize breast milk time inclusion , expect remain infant formula 4 week , pasteurize breast milk least 2 week follow treatment initiation . Preterm infant expect receive fresh breast milk 4 week follow treatment initiation . Informed consent obtain . Expected stay hospital le 4 week first dose study drug . Criteria ensure disease treatment affect growth development , e.g . brain disease , necrotizing enterocolitis . Enrolled another concurrent clinical intervention study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Weeks</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>rhBSSL</keyword>
	<keyword>preterm infant</keyword>
	<keyword>Swedish Orphan Biovitrum</keyword>
	<keyword>growth velocity</keyword>
	<keyword>Prevention growth restriction</keyword>
</DOC>